Validation of Fully Automated Robust Multicriterial Treatment Planning for Head and Neck Cancer IMPT.


Journal

International journal of radiation oncology, biology, physics
ISSN: 1879-355X
Titre abrégé: Int J Radiat Oncol Biol Phys
Pays: United States
ID NLM: 7603616

Informations de publication

Date de publication:
27 Jan 2024
Historique:
received: 04 07 2023
revised: 10 12 2023
accepted: 23 12 2023
medline: 29 1 2024
pubmed: 29 1 2024
entrez: 29 1 2024
Statut: aheadofprint

Résumé

Our purpose was to compare robust intensity modulated proton therapy (IMPT) plans, automatically generated with wish-list-based multicriterial optimization as implemented in Erasmus-iCycle, with manually created robust clinical IMPT plans for patients with head and neck cancer. Thirty-three patients with head and neck cancer were retrospectively included. All patients were previously treated with a manually created IMPT plan with 7000 cGy dose prescription to the primary tumor (clinical target volume [CTV]7000) and 5425 cGy dose prescription to the bilateral elective volumes (CTV5425). Plans had a 4-beam field configuration and were generated with scenario-based robust optimization (21 scenarios, 3-mm setup error, and ±3% density uncertainty for the CTVs). Three clinical plans were used to configure the Erasmus-iCycle wish-list for automated generation of robust IMPT plans for the other 30 included patients, in line with clinical planning requirements. Automatically and manually generated IMPT plans were compared for (robust) target coverage, organ-at-risk (OAR) doses, and normal tissue complication probabilities (NTCP). No manual fine-tuning of automatically generated plans was performed. For all automatically generated plans, voxel-wise minimum D Erasmus-iCycle was able to produce IMPT dose distributions fully automatically with similar (robust) target coverage and improved OAR doses and NTCPs compared with clinical manual planning, with negligible hands-on planning workload.

Identifiants

pubmed: 38284961
pii: S0360-3016(23)08308-6
doi: 10.1016/j.ijrobp.2023.12.034
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Merle Huiskes (M)

Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: m.huiskes@lumc.nl.

Wens Kong (W)

Department of Radiotherapy, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

Michelle Oud (M)

Department of Radiotherapy, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

Koen Crama (K)

Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands; HollandPTC, Delft, The Netherlands.

Coen Rasch (C)

Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands; HollandPTC, Delft, The Netherlands.

Sebastiaan Breedveld (S)

Department of Radiotherapy, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

Ben Heijmen (B)

Department of Radiotherapy, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

Eleftheria Astreinidou (E)

Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands.

Classifications MeSH